Presentation Information
[28-14-am10S]Differences in Safety Signal Detection Between Osimertinib and First- and Second-Generation EGFR-TKIs: A Pharmacovigilance Study Using a Spontaneous Reporting System
○Tomoya Sugimoto1,2, Yoshihiro Noguchi1, Rikuto Masuda1, Yukio Toyama2, Mitsuru Saguchi1, Tomoaki Yoshimura1 (1. Gifu pharm univ, 2. Toyota Memorial Hospital)